Roberto Piva

18PUBLICATIONS
52CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)NanomedicineMolecular targetsCancer cell biologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 25, 2026
Rapid minigene workflow for functional reclassification of splicing variants in hereditary cancer diagnostics.

|Aug 13, 2026
Correction: Audrito et al. NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in Melanoma. Cancers 2020, 12, 3855.

|May 13, 2026
MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma.

|Feb 13, 2026
Dual Targeting of IDH2 and the Ubiquitin-Proteasome System Reveals a Functional Vulnerability in Breast Cancer Models.

Nariman Gharari, Elisabetta Mereu, Beatrice Luciano

|Jan 25, 2025
Unlocking the Therapeutic Potential of Algae-Derived Compounds in Hematological Malignancies.

Tamara Vujović, Tina Paradžik, Sanja Babić Brčić

|Oct 16, 2024
IDH2 Inhibitors Gain a Wildcard Status in the Cancer Therapeutics Competition.

Roberto Piva, Nariman Gharari, Maria Labrador

Pageof 3

Frequent Collaborators

4 joint publications

Elisa Pellegrino

4 joint publications

Chiara Riganti

4 joint publications

Silvia Deaglio

3 joint publications

Tina Paradzik